Mekonos
is a California-based biotechnology firm that develops and commercializes cell therapies-on-a-chip systems for the healthcare industry... Read moreMekonos
is a California-based biotechnology firm that develops and commercializes cell therapies-on-a-chip systems for the healthcare industry... Read more
News
May 03, 2024
Business Wire
Press Release: Mekonos : Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing
May 05, 2023
BioPharma-Reporter
Mekonos: Mekonos announces research collaboration with Bit.Bio to advance cell engineering
Apr 06, 2023
StreetInsider
Press Release: Mekonos : Mekonos to Present at 2023 Cell & Gene Meeting on the Med
Dec 14, 2021
BioSpace
Mekonos: Opentrons' subsidiary Neochromosome and Mekonos announce new partnership to advance cell engineering for personalized medicine
Nov 22, 2021
Global Legal Chronicle
Mekonos: Mekonos's $25 Million Series A Financing Round
Nov 12, 2021
AZoM
Mekonos: TDK Backs Scalable Cell Engineering with Mekonos
Nov 11, 2021
FinanzNachrichten
Mekonos: Debiopharm International SA: Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos
Nov 10, 2021
FinSMEs
Mekonos: Mekonos Raises $25M in Series A Funding
Nov 10, 2021
Silicon Valley Daily
Mekonos: Mekonos Lands $25 Million Oversubscribed Round
Dec 07, 2020
FinTech InShorts
Mekonos: Sber500: Accepts Third Batch Entries -
